Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
32.32 CHF | +0.75% | +0.15% | +19.44% |
May. 22 | Sandoz: Marketing authorization for Wyost and Jubbonti in the EU | CF |
May. 22 | Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
SANDOZ GROUP AG | Generic Pharmaceuticals | +0.75% | +0.15% | +19.44% | - | - | 15.08B |
Technical Rankings Surperformance
- Stock Market
- Equities
- SDZ Stock
- Charts Sandoz Group AG
- Comparison Chart